DCM
PRCT icon

Driehaus Capital Management’s Procept Biorobotics PRCT Stock Holding History

Driehaus Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-129,153
Closed -$7.52M – 480
2025
Q1 		$7.52M Sell
129,153
-188,982
-59% -$12.9M 0.07% 277
2024
Q4 		$25.6M Sell
318,135
-33,886
-10% -$2.89M 0.21% 142
2024
Q3 		$28.2M Buy
352,021
+2,627
+0.8% +$187K 0.24% 133
2024
Q2 		$21.3M Buy
349,394
+71,930
+26% +$4.28M 0.21% 143
2024
Q1 		$13.7M Sell
277,464
-93,065
-25% -$4.43M 0.14% 204
2023
Q4 		$15.5M Buy
370,529
+130,199
+54% +$4.43M 0.19% 183
2023
Q3 		$7.89M Sell
240,330
-534
-0.2% -$18.2K 0.1% 239
2023
Q2 		$8.51M Sell
240,864
-640,617
-73% -$21.2M 0.11% 230
2023
Q1 		$25M Sell
881,481
-4,109
-0.5% -$145K 0.35% 85
2022
Q4 		$36.8M Buy
885,590
+14,716
+2% +$632K 0.55% 50
2022
Q3 		$36.1M Buy
870,874
+107,989
+14% +$4.31M 0.55% 53
2022
Q2 		$24.9M Buy
762,885
+582,789
+324% +$21.2M 0.4% 75
2022
Q1 		$6.3M Buy
+180,096
New +$4.33M 0.08% 285

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Driehaus Capital Management's PRCT Position: Q2 2025 in Review

Driehaus Capital Management sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 129,153 shares — an estimated $7.52M sold.

Driehaus Capital Management first reported a position in PRCT in Q1 2022 and held it in 13 quarters. The position peaked at $36.8M in Q4 2022. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Driehaus Capital Management reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 129,153 Procept Biorobotics shares in Q2 2025, an estimated $7.52M.
  • Driehaus Capital Management first reported a position in Procept Biorobotics in Q1 2022 and held it in 13 quarters.
  • Driehaus Capital Management's Procept Biorobotics position peaked at $36.8M in Q4 2022.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Driehaus Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.